Ancora Advisors, LLC Abbott Laboratories Transaction History

Ancora Advisors, LLC

$4.08 Billion
Q4 2024

A detailed history of Ancora Advisors, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Ancora Advisors, LLC holds 56,819 shares of ABT stock, worth $7.51 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

56,819

Previous 57,702 1.53%

Holding current value

$7.51 Million

Previous $6.58 Million 2.31%

% of portfolio

0.16%

Previous 0.16%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$111.93 - $119.39 $98,834 - $105,421	-883 Reduced 1.53%	56,819 $6.43 Million
Q3 2024 Nov 14, 2024	SELL	$100.07 - $118.13 $19,213 - $22,680	-192 Reduced 0.33%	57,702 $6.58 Million
Q2 2024 Aug 14, 2024	SELL	$100.73 - $112.44 $214,252 - $239,159	-2,127 Reduced 3.54%	57,894 $6.02 Million
Q1 2024 May 15, 2024	SELL	$109.52 - $120.96 $221,778 - $244,944	-2,025 Reduced 3.26%	60,021 $6.82 Million
Q4 2023 Feb 14, 2024	SELL	$90.19 - $110.4 $74,136 - $90,748	-822 Reduced 1.31%	62,046 $6.83 Million
Q3 2023 Nov 14, 2023	SELL	$95.53 - $114.62 $148,358 - $178,004	-1,553 Reduced 2.41%	62,868 $6.09 Million
Q2 2023 Aug 14, 2023	BUY	$100.78 - $112.29 $292,161 - $325,528	2,899 Added 4.71%	64,421 $7.02 Million
Q1 2023 May 15, 2023	BUY	$96.86 - $114.01 $46,880 - $55,180	484 Added 0.79%	61,522 $6.23 Million
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $171,108 - $200,736	1,800 Added 3.04%	61,038 $6.7 Million
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $220,903 - $255,764	-2,283 Reduced 3.71%	59,238 $5.73 Million
Q2 2022 Aug 15, 2022	SELL	$102.07 - $123.37 $28,171 - $34,050	-276 Reduced 0.45%	61,521 $6.68 Million
Q1 2022 May 16, 2022	BUY	$114.02 - $139.04 $408,647 - $498,319	3,584 Added 6.16%	61,797 $7.32 Million
Q1 2022 May 13, 2022	SELL	$114.02 - $139.04 $507,845 - $619,284	-4,454 Reduced 7.11%	58,213 $6.98 Million
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $3,928 - $4,809	34 Added 0.05%	62,667 $8.82 Million
Q3 2021 Nov 15, 2021	BUY	$116.66 - $129.06 $532,086 - $588,642	4,561 Added 7.85%	62,633 $7.4 Million
Q2 2021 Aug 13, 2021	SELL	$105.79 - $124.53 $14,916 - $17,558	-141 Reduced 0.24%	58,072 $6.73 Million
Q1 2021 May 14, 2021	SELL	$108.84 - $128.23 $52,134 - $61,422	-479 Reduced 0.82%	58,213 $6.98 Million
Q4 2020 Feb 12, 2021	SELL	$105.0 - $114.42 $186,060 - $202,752	-1,772 Reduced 2.93%	58,692 $6.43 Million
Q3 2020 Nov 13, 2020	BUY	$91.64 - $111.29 $164,585 - $199,876	1,796 Added 3.06%	60,464 $6.58 Million
Q2 2020 Aug 14, 2020	SELL	$76.57 - $98.0 $2,756 - $3,528	-36 Reduced 0.06%	58,668 $5.36 Million
Q1 2020 May 14, 2020	SELL	$62.82 - $91.86 $153,783 - $224,873	-2,448 Reduced 4.0%	58,704 $4.63 Million
Q4 2019 Feb 14, 2020	SELL	$78.51 - $87.4 $127,029 - $141,413	-1,618 Reduced 2.58%	61,152 $5.31 Million
Q3 2019 Nov 14, 2019	BUY	$81.84 - $88.74 $4,828 - $5,235	59 Added 0.09%	62,770 $5.25 Million
Q2 2019 Aug 12, 2019	BUY	$72.88 - $85.0 $364 - $425	5 Added 0.01%	62,711 $5.27 Million
Q1 2019 May 15, 2019	BUY	$66.22 - $80.06 $4.15 Million - $5.02 Million	62,706 New	62,706 $5.01 Million
Q4 2018 Feb 15, 2019	SELL	$65.56 - $74.27 $4.96 Million - $5.62 Million	-75,694 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$60.81 - $73.36 $100,640 - $121,410	-1,655 Reduced 2.14%	75,694 $5.55 Million
Q2 2018 Aug 10, 2018	SELL	$57.57 - $63.54 $236,900 - $261,467	-4,115 Reduced 5.05%	77,349 $4.72 Million
Q1 2018 May 15, 2018	BUY	$56.27 - $63.62 $4.58 Million - $5.18 Million	81,464 New	81,464 $4.88 Million
Q4 2017 Feb 14, 2018	SELL	$53.68 - $57.47 $3.92 Million - $4.19 Million	-72,957 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$48.06 - $53.64 $3.51 Million - $3.91 Million	72,957	72,957 $3.89 Million

Others Institutions Holding ABT

# of Institutions

3,356

Shares Held

1.36B

Call Options Held

10.6M

Put Options Held

8.73M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $231B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ancora Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ancora Advisors, LLC with notifications on news.

Account

Ancora Advisors, LLC Abbott Laboratories Transaction History